GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

CFTRinh-172   Click here for help

GtoPdb Ligand ID: 4153

Compound class: Synthetic organic
Comment: CFTRinh-172 binds within the permeation pathway. However, inhibition is not voltage dependent [3] and results from a collapse of the extracellular mouth of the pore (involving rearrangements of TM8, TM12 and TM1) which occurs after inhibitor binding [2-3,6]. Low apparent potency for the pig CFTR (pIC50 5.7) can be increased by introducting mutations in TM8 (introducing the corresponding human residues), despite TM8 not being part of the CFTRinh-172 binding site [2]. CFTRinh-172 has low water solubility, but more soluble analogues have been developed [5]. It has off-target effects on ClC-2 [1], and volume-sensitive outwardly rectifying Cl conductance (VSORC) [4].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 115
Molecular weight 409.01
XLogP 3.97
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES S=C1SC(=Cc2ccc(cc2)C(=O)O)C(=O)N1c1cccc(c1)C(F)(F)F
Isomeric SMILES S=C1SC(=Cc2ccc(cc2)C(=O)O)C(=O)N1c1cccc(c1)C(F)(F)F
InChI InChI=1S/C18H10F3NO3S2/c19-18(20,21)12-2-1-3-13(9-12)22-15(23)14(27-17(22)26)8-10-4-6-11(7-5-10)16(24)25/h1-9H,(H,24,25)
InChI Key JIMHYXZZCWVCMI-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Cuppoletti J, Chakrabarti J, Tewari KP, Malinowska DH. (2014)
Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents.
Am J Physiol Cell Physiol, 307 (5): C479-92. [PMID:25009109]
2. Gao X, Yeh HI, Yang Z, Fan C, Jiang F, Howard RJ, Lindahl E, Kappes JC, Hwang TC. (2024)
Allosteric inhibition of CFTR gating by CFTRinh-172 binding in the pore.
Nat Commun, 15 (1): 6668. [PMID:39107303]
3. Kopeikin Z, Sohma Y, Li M, Hwang TC. (2010)
On the mechanism of CFTR inhibition by a thiazolidinone derivative.
J Gen Physiol, 136 (6): 659-71. [PMID:21078867]
4. Melis N, Tauc M, Cougnon M, Bendahhou S, Giuliano S, Rubera I, Duranton C. (2014)
Revisiting CFTR inhibition: a comparative study of CFTRinh -172 and GlyH-101 inhibitors.
Br J Pharmacol, 171 (15): 3716-27. [PMID:24758416]
5. Sonawane ND, Verkman AS. (2008)
Thiazolidinone CFTR inhibitors with improved water solubility identified by structure-activity analysis.
Bioorg Med Chem, 16 (17): 8187-95. [PMID:18691893]
6. Young PG, Levring J, Fiedorczuk K, Blanchard SC, Chen J. (2024)
Structural basis for CFTR inhibition by CFTRinh-172.
Proc Natl Acad Sci U S A, 121 (10): e2316675121. [PMID:38422021]